A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia

NCT00249145 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

349

Enrollment

INDUSTRY

Sponsor class

Conditions

Dementia
Alzheimer Disease
Dementia, Vascular

Interventions

DRUG: risperidone

Sponsor

Janssen Pharmaceutica N.V., Belgium